Insight

Vittorio Studiale: Late-line mCRC – an evidence-based algorithm for the clinical practice in 2024

Vittorio Studiale/X

Nov 19, 2024, 20:59

Vittorio Studiale: Late-line mCRC – an evidence-based algorithm for the clinical practice in 2024

Vittorio Studiale, Medical Oncology Resident at Pisa University Hospital, shared a post on X about a recent paper by him and colleagues published in Nature Reviews Clinical Oncology:

“Late-line mCRC: an evidence-based algorithm for the clinical practice in 2024.

Proud and thrilled to share our review on the topic now online in Nature Reviews Clinical Oncology.”

“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm.”

Authors: Paolo Ciracì, Vittorio Studiale, Ada Taravella, Carlotta Antoniotti, Chiara Cremolini.

Vittorio Studiale: Late-line mCRC - an evidence-based algorithm for the clinical practice in 2024

For more posts like this, visit oncodaily.com.

Ada Taravella cancer Carlotta Antoniotti Chiara Cremolini mCRC Metastatic colorectal cancer Nature Reviews Clinical Oncology OncoDaily Oncology Paolo Ciracì Vittorio Studiale

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage